News Daiichi Sankyo and AstraZeneca Report the US FDA’s Approval of Enhertu for HER2 Low/Ultralow Metastatic Breast Cancer (MBC), Progressed on Endocrine TherapiesBySenior EditorJanuary 28, 20250Comments
News Alvotech & Teva Reports the US FDA’s BLA Acceptance of AVT05 (Biosimilar, Simponi & Simponi Aria)ByRidhi RastogiJanuary 28, 20250Comments
News Neurocrine Biosciences and Takeda Amend Partnership to Develop and Commercialize Osavampator in JapanByRidhi RastogiJanuary 28, 20250Comments
INSIGHTS+ Key Takeaways of J.P. Morgan Healthcare Conference 2025ByHimanshu SehgalJanuary 28, 20250Comments
VIEWPOINTS Cardiology Care and Beyond: Mina Makar from AstraZeneca in a Riveting Dialogue Exchange with PharmaShotsBySaurabh ChaubeyJanuary 27, 20250Comments
News Novo Nordisk Completes P-Ib/IIa Study of Subcutaneous Amycretin in Overweight or Obese PeopleByRidhi RastogiJanuary 27, 20250Comments
News Merck and Eisai Reveal Latest Data from P-III (LEAP-015) Trial of Keytruda (pembrolizumab) and Lenvima (lenvatinib) Regimen to Treat Gastroesophageal AdenocarcinomaByRidhi RastogiJanuary 27, 20250Comments
News Dyne Therapeutics’ DYNE-101 Secures the US FDA’s Fast Track Designation for Treating DM1ByDipanshu DixitJanuary 27, 20250Comments
News China’s NMPA Accepts NDA for Akeso’s Gumokimab to Treat Moderate to Severe PsoriasisByRidhi RastogiJanuary 27, 20250Comments
